Preclinical properties of the thiocarboxanilide UC-781 as a potential virucidal compound against HIV

被引:1
作者
Balzarini, J [1 ]
机构
[1] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
关键词
D O I
10.1097/00002030-200102001-00054
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:S38 / S39
页数:2
相关论文
共 3 条
[1]   Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent [J].
Balzarini, J ;
Naesens, L ;
Verbeken, E ;
Laga, M ;
Van Damme, L ;
Parniak, M ;
Van Mellaert, L ;
Anné, J ;
De Clercq, E .
AIDS, 1998, 12 (10) :1129-1138
[2]  
Balzarini J, 1996, MOL PHARMACOL, V50, P394
[3]   Chemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: Retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptase [J].
Borkow, G ;
Barnard, J ;
Nguyen, TM ;
Belmonte, A ;
Wainberg, MA ;
Parniak, MA .
JOURNAL OF VIROLOGY, 1997, 71 (04) :3023-3030